Programme

12:30 - 13:30

Registration

13:30 - 13:45

Welcome & Opening

Katja Schenke-Layland, Vice-President for Research, University of Tübingen

13:45 - 15:35

Session 1: Neurodevelopment

13:45 - 14:35 Keynote 1: Jürgen Knoblich (Vienna, Austria)
Cerebral Organoids: Growing human brain tissue from stem cells to study development and disease

14:35 - 14:55 T01: Oleg Vinogradov (University of Tübingen, Germany)
Rescuing hyperexcitable network activity in hiPSC model of CACNA1E-related developmental and epileptic encephalopathy

14:55 - 15:15 T02: Cesar Mateo Bastidas Betancourt (German Primate Center Göttingen, Germany)
Using Brain Organoids to Reveal the Roles of ZNF90 and OVOL2 in Hominid Brain Development and Evolution

15:15 - 15:35 T03: Christin Struffert (University Hospital Muenster, Germany)
Convergent Mechanisms of Risk Genes in Psychiatric Disorders: A Functional Genomic and Drug Screening Approach

15:35 - 16:00

Coffee break

16:00 - 17:50

Session 2: Neurosensory

16:00 - 16:50 Keynote 2: Botond Roska (Basel, Switzerland)
A new therapeutic modality for eye diseases

16:50 - 17:10 T0:4: Kerstin Nagel-Wolfrum (Johannes Gutenberg University Mainz, Germany)
Single-cell analysis reveals impaired Müller glia-mediated intercellular communication in USH1C retinal organoids

17:10 - 17:30 T05: Maria Pavlou (Center for Regenerative Therapies TU Dresden, Germany)
Transplanted hiPSC-derived photoreceptors differentially survive and mature in host mice with mild and severe retinal degeneration

17:30 - 17:45 S01: Anastasiia Tourbier (MaxWell Biosystems AG)
High-Density Microelectrode Arrays for Functional Insight into iPSC-Derived Models

17:45 - 17:50 Lightning Talks: Katerina Apostolidi; Lucia Occhigrossi; Clemens Sauter; Rebeka Stelcz; Zeynep Yentür

17:50 - 19:20

Poster Session 1

Odd numbers

19:30 - 21:30

Reception

Alte Aula, Münzgasse 30, 72070 Tübingen

09:00 - 10:25

Session 3: Neurodegeneration I

09:00 - 09:50 Keynote 3: Julia TCW (Boston, USA)
Deciphering functional mechanisms of Alzheimer's risk APOE4 using iPSC, human brains and chimeric models

09:00 - 10:10 T06: Sascha Koppes-den Hertog (Vrije Universiteit Amsterdam, The Netherlands)
Cholesterol regulates astrocyte reactivity and is dysregulated by ApoE4

10:10 - 10:25 S02: Mitzy Rios de Anda (bit.bio)
An in vitro tool kit to study complex cellular interactions in the CNS during physiological and pathological conditions

10:25 - 10:55

Coffee break

10:55 - 12:05

Session 3: Neurodegeneration I

10:55 - 11:15 T07: Virginia Cora (Maastricht University, The Netherlands)
Modelling human midbrain aging: an iPSC-based platform to explore senescence and age-related neurodegenerative disorders

11:15 - 11:35 T08: Jacob Helm (DZNE Tübingen, Germany)
SNP-guided targeting strategy in spinocerebellar ataxia type 3 using allele-specific antisense oligonucleotides

11:35 - 11:50 S03: Katharina Debowski (STEMCELL Technologies)
Rapid Generation of Functional Forebrain Neurons from Human Pluripotent Stem Cells Using a Novel NGN2 mRNA-LNP Platform

11:50 - 12:05 S04: Markus Uhrig (OLS OMNI Life Science)
Reliable 3D Cell Models High-Yield Cultivation Meets Precision Sorting

12:05 - 13:00

Lunch break

13:00 - 14:30

Workshops (parallel)

(W1) Basic Principles of science communication
Markus Gottschling (University of Tübingen, Germany)

(W2) Planning my next step – Career development inside/ outside academia
Silke Thul, Sabrina Lehner (DZNE Bonn, Germany)

(W3) Technology Transfer Trivia
Patrick Wunderlich, Dennis de Coninck (DZNE Bonn, Germany)

(W4) Organoid Intelligence
Alina Wernick (University of Tübingen) and Miriam Klopotek (University of Stuttgart)

14:30 - 15:00

Coffee break

15:00 - 16:55

Session 4: Neuroglia

15:00 - 15:50 Keynote 4: Elly Hol (Utrecht, The Netherlands)
Human iPSC-derived models to study astrocytes in disease

15:50 - 16:10 T09: Taisia Rolova (University of Helsinki, Finland)
Inflammation-induced lysosomal dysfunction in human iPSC-derived microglia is exacerbated by APOE 4/4 genotype

16:10 - 16:30 T10: Vanessa Donega (Amsterdam UMC, The Netherlands)
Disease and age-dependent effects on microglia in the subventricular zone of the human brain

16:30 - 16:50 T11: Weronika Tomaszewska (Research Network Łukasiewicz, Poland)
Interplay of serum lipids and microglia in the susceptibility to the long-term behavioral effects of adverse childhood experiences

16:50 - 16:55 Lightning Talks: Stefanie Fruhwürth; Gianluca Morganti; Marc Oudart; Helena Pivoňková; Karan Sharma

16:55 - 18:30

Poster session 2

Even numbers

19:30

Conference Dinner

upon invitation only

09:00 - 10:30

Session 5: Neurodegeneration II

09:00 - 09:50 Keynote 5: Anna Williams (Edinburgh, UK)
Understanding heterogeneity to help CNS neurodegenerative disorders

09:50 - 10:10 T12: Ines Elbini (Institut Pasteur De Tunis, Tunisia)
Venom peptides targeting Kv1.3 channels reduce alpha-synuclein aggregation in stem cell models of Parkinson’s disease

10:10 - 10:30 T13: Jan Raska (Masaryk University Brno, Czech Republic)
SORLA-associated Alzheimer’s disease modelling in iPSC-Derived Neurons and Cerebral Organoids

10:30 - 11:00

Coffee break

11:00 - 11:50

Session 6: Emerging Technologies

11:00 - 11:50 Keynote 6: Martin Kampmann (San Francisco, USA)
Unbiased CRISPR screens to uncover mechanisms of brain function and disease

11:50 - 12:10 T14: Linus Wiora (DZNE Tübingen, Germany)
Transcriptional Silencing of AAV in Human iPSC-Derived Neural Cells Is Overcome by Blocking Host SUMOylation

12:10 - 12:30 T15: Sven Fengler (DZNE Bonn, Germany)
Automated iPSC differentiation for High-Content Microphysiological Systems

12:30 - 12:50 T16: Peter Jones (NMI Reutlingen, Germany)
Electrophysiology inside neural spheroids using mesh microelectrode arrays

12:50 - 14:00

Wrap-up & lunch

Information

Information about the different session, registration fees, travel stipends etc…

Workshops

These workshops provide training in essential “soft skills” and encourage critical thinking and discussion.

Keynote Speakers

Infos about our keynote speakers: They all utilize stem cells to investigate neurosciece, from development to neurodegeneration and beyond.